Xenon Pharmaceuticals’ lead drug greatly reduced the frequency of seizures in a Phase 3 epilepsy study, supporting the company’s plans to file for FDA approval in the third quarter.
The drug, azetukalner, would be Xenon’ …
Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.
An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.
Biotech’s best-funded AI startup detailed its first AI model on Tuesday, giving a glimpse at what it’s been doing since launching out of stealth nearly
To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on
Aldeyra Therapeutics was hoping the third time would be the charm for its dry eye drug this St. Patrick’s Day. No such luck. The FDA
Xenon Pharmaceuticals’ lead drug greatly reduced the frequency of seizures in a Phase 3 epilepsy study, supporting the company’s plans to file for FDA approval in the third quarter.
The drug, azetukalner, would be Xenon’ …